Nathan Treybeck
Stock Analyst at Wells Fargo
(0.68)
# 4,187
Out of 5,058 analysts
72
Total ratings
26.2%
Success rate
-4.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Reiterated: Buy | $168 → $150 | $108.64 | +38.07% | 22 | Oct 6, 2026 | |
| RMD ResMed | Rated: Hold | $225 → $215 | $238.97 | -10.03% | 4 | Aug 7, 2026 | |
| SOLV Solventum | Reiterated: Hold | $89 | $85.81 | +3.72% | 1 | Aug 6, 2026 | |
| PRCT PROCEPT BioRobotics | Downgraded: Hold | $34 → $19 | $17.57 | +8.14% | 26 | Aug 5, 2026 | |
| LMAT LeMaitre Vascular | Reiterated: Hold | $94 → $104 | $80.82 | +28.68% | 8 | May 6, 2026 | |
| ITGR Integer Holdings | Downgraded: Hold | $132 → $80 | $126.70 | -36.86% | 11 | Oct 23, 2025 |
iRhythm Holdings
Oct 6, 2026
Reiterated: Buy
Price Target: $168 → $150
Current: $108.64
Upside: +38.07%
ResMed
Aug 7, 2026
Rated: Hold
Price Target: $225 → $215
Current: $238.97
Upside: -10.03%
Solventum
Aug 6, 2026
Reiterated: Hold
Price Target: $89
Current: $85.81
Upside: +3.72%
PROCEPT BioRobotics
Aug 5, 2026
Downgraded: Hold
Price Target: $34 → $19
Current: $17.57
Upside: +8.14%
LeMaitre Vascular
May 6, 2026
Reiterated: Hold
Price Target: $94 → $104
Current: $80.82
Upside: +28.68%
Integer Holdings
Oct 23, 2025
Downgraded: Hold
Price Target: $132 → $80
Current: $126.70
Upside: -36.86%